🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesGLP-1 and peripheral arterial disease — claudication improvement data Page 2

GLP-1 and peripheral arterial disease — claudication improvement data

Dr.CardioMD Sun, Mar 1, 2026 at 12:54 AM 8 replies 449 viewsPage 2 of 2
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Mar 1, 2026 at 3:44 AM#6

How do you know if you have sleep apnea? I'm 45M, BMI 38, and my wife says I snore loudly and sometimes stop breathing at night. I wake up exhausted every morning despite 7-8 hours in bed. Is it worth getting tested before or while on GLP-1 therapy?

34 3RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 31 others
Reply Quote Save Share Report
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Mar 1, 2026 at 4:01 AM#7

Your symptoms are classic for OSA and you should absolutely get tested. The gold standard is in-lab polysomnography, but home sleep testing (HST) is more accessible and adequate for most patients with a high pre-test probability like yours.

Quick screening tool: the STOP-BANG questionnaire

  • Snoring loudly? — Yes
  • Tired/sleepy during daytime? — Yes
  • Observed apneas? — Yes (wife reports)
  • Pressure (blood pressure elevated)? — Unknown
  • BMI >35? — Yes
  • Age >50? — No (but close)
  • Neck circumference >16 in (M)? — Likely at BMI 38
  • Gender male? — Yes

You have at least 5/8 positive responses, which classifies you as high risk. Ask your PCP for a sleep study referral. If you start GLP-1 therapy in the meantime, a baseline AHI will allow you to quantify the improvement over time — as the OP beautifully demonstrated.

20 8PharmHunterJen, TomTeleRx, DoseLogDan and 17 others
Reply Quote Save Share Report
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Mar 1, 2026 at 4:18 AM#8

I'll add that untreated OSA significantly worsens insulin resistance and makes weight loss harder. There's a bidirectional relationship: obesity causes OSA, and OSA worsens the metabolic derangements of obesity. Breaking this cycle with GLP-1/GIP therapy addresses both simultaneously.

Don't wait for the sleep study to start GLP-1 therapy if indicated for other reasons — the metabolic benefits begin immediately. But do get the baseline sleep study so you have documentation of improvement, which matters for insurance coverage decisions down the road.

2 13carlos_SATX, sophie_paris
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 1, 2026 at 4:35 AM#9

Sleep apnea is one of the most underdiagnosed conditions in the obesity population. Estimates suggest 80-90% of moderate-to-severe OSA is undiagnosed. If you have symptoms (snoring, witnessed apneas, daytime sleepiness, morning headaches, nocturia), please raise this with your healthcare provider. Treatment — whether with CPAP, weight loss, or both — can be transformative.

16 10BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 13 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register